Changes of gastric mucosal architecture during long‐term omeprazole therapy: results of a randomized clinical trial

Lars Lundell(Karolinska Institutet), Martha Lamm(AstraZeneca (Sweden)), L. Wallin(Odense University Hospital), Pekka Miettinen(Kuopio University Hospital), Bengt Liedman(Sahlgrenska University Hospital), Jan Gunnar Hatlebakk(Haukeland University Hospital), Niilo Havu(Amphia Ziekenhuis), Kristina Levander(Ersta sjukhus), H. E. Myrvold(St Olav's University Hospital), Anna Malm(AstraZeneca (Sweden)), Risto Julkunen(Kuopio University Hospital), A. Walan(Linköping University)
Alimentary Pharmacology & Therapeutics
February 14, 2006
10.1111/j.1365-2036.2006.02792.x
Cited by 89

Related Papers

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
|Gastroenterology|2000|544
A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop1 1Members of the workshop composed a group of international experts in BE from gastroenterology, surgery, pathology, molecular biology, outcomes, and epidemiology. Conference chairman: Prateek Sharma; conference moderator: Kenneth McQuaid; group leaders: John Dent, M. Brian Fennerty, Richard Sampliner, Stuart Spechler; participants: Alan Cameron, Douglas Corley, Gary Falk, John Goldblum, John Hunter, Janusz Jankowski, Lars Lundell, Brian Reid, Nicholas Shaheen, Amnon Sonnenberg, Kenneth Wang, and Wilfred Weinstein.
|Gastroenterology|2004|526
Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric Ulcer
|New England Journal of Medicine|1989|382
Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process
|Gastroenterology|2012|378
Cure of <i>Helicobacter pylori</i> infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial
|Gut|2003|220